<DOC>
	<DOCNO>NCT02300259</DOCNO>
	<brief_summary>The first purpose study evaluate effect itraconazole ( possibly diltiazem ) amount LY2623091 blood stream long body take get rid . The second purpose study evaluate effect LY2623091 amount simvastatin ( possibly tadalafil ) blood stream long body take get rid . The safety tolerability LY2623091 give itraconazole , simvastatin diltiazem tadalafil evaluate . There three group participant study . Results Groups 1 2 analyze study determine whether enroll participant Group 3 4 . The study expect last 40 day first dose follow-up ( inclusive ) . Screening may occur 28 day prior enrollment .</brief_summary>
	<brief_title>A Study LY2623091 Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Diltiazem</mesh_term>
	<criteria>Healthy participant determine medical history , physical examination , clinical laboratory test , electrocardiogram ( ECGs ) . Have body mass index ( BMI ) 18 32.0 kilogram per square meter ( kg/m^2 ) inclusive , screen Female participant must nonchildbearing potential In opinion investigator sponsor , unsuitable inclusion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>